On September 20, 2022, Nalanda India Equity Fund purchased 2.91 million equity shares, representing 2.6 per cent stake in Advanced Enzyme Technologies, worth Rs 78.62 crore via block deal, NSE data shows. The foreign portfolio investor bought shares at weighted average price of Rs 270.03 per share, data shows.
Advanced Enzyme surges 12% as Nalanda India Equity Fund ups stake by 3%
Advanced Vital Enzymes Private Limited, the promoter of Advanced Enzyme Technologies, has offloaded 2.57 million equity shares at a price of Rs 270.04 per share
 "equity market, stocks, share market")
Premium
Between December 2020 and February 2021, traders were supposed to maintain at least 25 per cent of the peak margin
On September 20, 2022, Nalanda India Equity Fund purchased 2.91 million equity shares, representing 2.6 per cent stake in Advanced Enzyme Technologies, worth Rs 78.62 crore via block deal, NSE data shows. The foreign portfolio investor bought shares at weighted average price of Rs 270.03 per share, data shows.
First Published: Sep 20 2022 | 09:55 AM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com
